Sponsor:
Stanford University
Code:
NCT05078723
Conditions
CYP2C19 Genetic Variants
Eligibility Criteria
Sex: All
Age: 18 - 45
Healthy Volunteers: Accepted
Interventions
Limonene
Brief summary:
Conditions
CYP2C19 Genetic Variants
Study ID
NCT05078723
Start date
Oct 30, 2021
Status verified date
Dec, 2024
Completion date
Dec, 2026
Anticipated
Primary completion date
Mar, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 45
Healthy Volunteers: Accepted
Enrollment
20 participants
Anticipated
Allocation
Non randomized
Intervention Model
Single group
Primary purpose
Basic Science
Arms
experimental: CYP2C19*2 and CYP2C19*3 Variants
experimental: Wildtype CYP2C19
Interventions
Limonene
Primary outcome measure
Central contacts
Locations
Stanford School of Medicine
Recruiting
Stanford, California, United States, 94305
Sponsor
Stanford University
Last update posted
Dec 16, 2024
Last verified
Dec, 2024
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Stanford University on 2024-12-16.